Trial intelligence / Profile preview

Tacrolimus Ointment in Paediatric Atopic Dermatitis

NCT00560326Phase 2Completed

Sponsor
Astellas Pharma
Start
Jun 2003
Modality
Small Molecules
Countries
5
01

Overview

A Phase 2 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Jun 2003; status: completed.

02

Drugs

Tacrolimus Ointment 0.1% Iwaki
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00560326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00560326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call